Home   Business   Life Science

Life Science




AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive


£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform


A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

A first look inside AstraZeneca's new £500m-plus global HQ and R&D centre on Cambridge Biomedical Campus

We tour the striking building that could redefine what a pharma business looks like


Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Expedeon becomes a preferred supplier for Babraham-based Cell Guidance Systems

Companies sign agreement for Lightning-Link Rapid Biotin technology


Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

Sosei Heptares receives $15m for cancer therapy milestone

Next-generation immuno-oncology candidate triggers AstraZeneca payment


How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company


Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

Abcam expects double digit revenue growth

Company says it is preparing for no-deal Brexit


AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

AstraZeneca announces changes as world-renowned cancer expert joins

CEO Pascal Soriot says company expects 'sustained growth' period as new R&D units and commercial units created


PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

PetaGene secures $2.1m after deal with big pharma

Genomics data compression firm was spun out of university in 2016


Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More